Hemostemix Inc(HEM-X)
TSX Venture

Today's Change
Delayed Last Update

Hemostemix Inc

707 - 7th Avenue SouthWest
Suite 1150
Calgary AB T2P 3H6 CAN
P: 905-580-4170
https://www.hemostemix.com

Sectors & Indices

Sector
Industry
Employees

    Profile

    Hemostemix Inc is a clinical-stage biotechnology company whose principal business is to develop, manufacture, and commercialize blood-derived stem cell therapies for medical conditions not adequately addressed by current treatments. Its product ACP-01 is derived from a patient's own blood and evaluated in clinical research for ischemic conditions, including Cardiovascular Ischemia, Peripheral Arterial Disease (PAD), Chronic Limb Threatening Ischemia (CLTI), and Vascular Dementia.

    Key Executives

    NameTitle
    Thomas SmeenkCEO/Co-Founder/Director/President
    Christina WuCFO

    More from The Globe

    Gildan stock is down, and looking good
    Signage is seen at Gildan Activewear Inc.'s annual meeting in Montreal, Tuesday, May 28, 2024. THE CANADIAN PRESS/Christinne Muschi
    the mover
    Why this money manager is buying Agnico Eagle, Nutrien and trimming Alphabet
    Illustration of Martin Pelletier for The Mover, June 19, 2026. Illustration by Joel Kimmel
    number cruncher
    Top U.S. stocks ranked by Trading Central’s quantitative model
    For Number Cruncher column in Globe Investor/ROB only.
    Wednesday’s analyst upgrades and downgrades
    A Dynamite clothing retail store is shown in Montreal, Friday, Nov. 15, 2024.
    number cruncher
    Seven Canadian small-cap stocks with cheap valuations
    For Number Cruncher column in Globe Investor/ROB only.
    Bullish on Freeport-McMoRan Inc.
    Monica Rizk
    Gildan shares sink 19 per cent on short seller report alleging inflated sales
    Gildan Activewear Inc. CEO Glenn Chamandy arrives to speak to the media following the company's annual meeting in Montreal on May 28, 2024.
    The highest-yielding stocks on the TSX, plus risk data
    The S&P TSX composite index screen at the TMX Market Centre in downtown Toronto is photographed on November 11, 2022.

    All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

    Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

    Financial data provided by Zacks Investment Research.